Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carla Gaggiano

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Seminars in Arthritis and Rheumatism|April 28, 2024
Thrombotic manifestations in pediatric Behcet syndrome: A multicenter comparative study from the EUROFEVER registryMaria Vincenza Mastrolia, Caterina Matucci-Cerinic, Seza Ozen, et al.
Frontiers in Medicine|September 9, 2024
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registriesAntonio Vitale, Judith Palacios-Olid, Valeria Caggiano, et al.
Frontiers in Medicine|September 30, 2024
Corrigendum: Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registriesAntonio Vitale, Judith Palacios-Olid, Valeria Caggiano, et al.
Ophthalmology and Therapy|November 4, 2023
Knowledge and Current Practices in Monogenic Uveitis: An International Survey by IUSG and AIDA NetworkCarla Gaggiano, Vishali Gupta, Rupesh Agrawal, et al.
Rheumatology (Oxford, England)|May 7, 2021
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA RegistryJurgen Sota, Donato Rigante, Rolando Cimaz, et al.
Therapeutic Advances in Musculoskeletal Disease|September 16, 2021
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA NetworkCarla Gaggiano, Donato Rigante, José Hernández-Rodríguez, et al.
Frontiers in Medicine|January 9, 2023
Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registryAntonio Vitale, Valeria Caggiano, Maria Cristina Maggio, et al.
Frontiers in Medicine|July 26, 2021
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA NetworkAntonio Vitale, Laura Obici, Marco Cattalini, et al.
Frontiers in Medicine|June 16, 2023
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs)Antonio Vitale, Valeria Caggiano, Isabel Silva, et al.
Frontiers in Pharmacology|September 12, 2019
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still DiseaseJurgen Sota, Donato Rigante, Piero Ruscitti, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Seminars in Arthritis and Rheumatism|April 28, 2024
Thrombotic manifestations in pediatric Behcet syndrome: A multicenter comparative study from the EUROFEVER registryMaria Vincenza Mastrolia, Caterina Matucci-Cerinic, Seza Ozen, et al.
Frontiers in Medicine|September 9, 2024
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registriesAntonio Vitale, Judith Palacios-Olid, Valeria Caggiano, et al.
Frontiers in Medicine|September 30, 2024
Corrigendum: Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registriesAntonio Vitale, Judith Palacios-Olid, Valeria Caggiano, et al.
Ophthalmology and Therapy|November 4, 2023
Knowledge and Current Practices in Monogenic Uveitis: An International Survey by IUSG and AIDA NetworkCarla Gaggiano, Vishali Gupta, Rupesh Agrawal, et al.
Rheumatology (Oxford, England)|May 7, 2021
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA RegistryJurgen Sota, Donato Rigante, Rolando Cimaz, et al.
Therapeutic Advances in Musculoskeletal Disease|September 16, 2021
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA NetworkCarla Gaggiano, Donato Rigante, José Hernández-Rodríguez, et al.
Frontiers in Medicine|January 9, 2023
Canakinumab as first-line biological therapy in Still's disease and differences between the systemic and the chronic-articular courses: Real-life experience from the international AIDA registryAntonio Vitale, Valeria Caggiano, Maria Cristina Maggio, et al.
Frontiers in Medicine|July 26, 2021
Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome-Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA NetworkAntonio Vitale, Laura Obici, Marco Cattalini, et al.
Frontiers in Medicine|June 16, 2023
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs)Antonio Vitale, Valeria Caggiano, Isabel Silva, et al.
Frontiers in Pharmacology|September 12, 2019
Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still DiseaseJurgen Sota, Donato Rigante, Piero Ruscitti, et al.
Pageof 9